Ulcerative Colitis

Patients with ulcerative colitis who achieve more rigorous treatment endpoints are at lower risk for relapse than patients who only achieve clinical remission, according to study results.

Healio Gastroenterology presents the following reports on the most recent research on inflammatory bowel disease.

One in eight patients with inflammatory bowel disease are food insecure and lack social support, according to research published in Clinical Gastroenterology and Hepatology.

Features of inflammatory bowel disease differed between children with primary sclerosing cholangitis and those without it, similar to adult patients, according to study results.

Frailty was independently associated with mortality in a large cohort of patients with inflammatory bowel disease, according to study results.

Zeposia may be an efficacious new oral therapy option with a favorable risk-benefit profile for patients with ulcerative colitis.

In newly issued guidelines, the American Gastroenterological Association did not recommend using probiotics for most digestive conditions.

Data from Digestive Disease Week showed that aspirin nearly doubled the risk for serious upper gastrointestinal bleeds in older adults. It was the top story in gastroenterology last week.

Patients with late-onset inflammatory bowel disease had a greater recurrence of colorectal cancer than patients with early-onset, despite a shorter disease duration and strictly following recommended endoscopic surveillance guidelines, according to data from Digestive Disease Week.

No correlation was seen between dietary gluten intake and the risk for incidence Crohn’s disease or ulcerative colitis among women without celiac disease, according to data from Digestive Disease Week.